Cash on Hand for Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported cash and short-term investments is $5.80B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingCash on HandSwitch metric
Latest period
$5.80B
YoY change
-17.5%
5Y CAGR
+4.7%
Peak year (2021)
$10.73B
Latest annual
$5.80B
Cash on Hand history chart for Moderna (MRNA) from 2016 to 2025
Cash on Hand history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $5.80B | -17.5% | ||
| 2024 | $7.03B | -18.4% | ||
| 2023 | $8.60B | -13.1% | ||
| 2022 | $9.90B | -7.7% | ||
| 2021 | $10.73B | +132.8% | ||
| 2020 | $4.61B | +317.8% | ||
| 2019 | $1.10B | -27.5% | ||
| 2018 | $1.52B | +101.2% | ||
| 2017 | $756.03M | -28.6% | ||
| 2016 | $1.06B | — |
Cash on Hand values are taken from Moderna's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual cash and short-term investments for Moderna (MRNA) came in at $5.80B – declined 17.5% year-over-year.
Moderna cash and short-term investments compound annual growth for the 2020–2025 (5 years) window is +4.7%, with the latest reading among the more recent periods of the dataset.
Moderna cash and short-term investments plunged from $10.73B in 2021 to $5.80B in 2025, a 45.9% drawdown.
Across the available history, cash and short-term investments reached its high of $10.73B in 2021 and its low of $756.03M in 2017.
Among 8 Healthcare peers, Moderna (MRNA) ranks 7th; the peer median for cash and short-term investments is $11.85B.
Moderna Cash on Hand by Year
Moderna Cash on Hand 2025: $5.80B
Moderna cash and short-term investments in 2025 was $5.80B, declined 17.5% below 2024.
Moderna Cash on Hand 2024: $7.03B
Moderna cash and short-term investments in 2024 was $7.03B, declined 18.4% below 2023.
Moderna Cash on Hand 2023: $8.60B
Moderna cash and short-term investments in 2023 was $8.60B, declined 13.1% below 2022.
Moderna Cash on Hand 2022: $9.90B
Moderna cash and short-term investments in 2022 was $9.90B, declined 7.7% below 2021.
Moderna Cash on Hand 2021: $10.73B
Moderna cash and short-term investments in 2021 was $10.73B.
See more financial history for Moderna (MRNA).
Sector peers — Cash on Hand
Companies in the same sector as Moderna, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Moderna's cash and short-term investments?
- Latest reported cash and short-term investments for Moderna (MRNA) is $5.80B (period ending December 31, 2025).
How has Moderna cash and short-term investments changed year-over-year?
- Moderna (MRNA) cash and short-term investments changed -17.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Moderna cash and short-term investments?
- Moderna (MRNA) cash and short-term investments compound annual growth rate is +4.7% over the most recent 5 years available.
When did Moderna cash and short-term investments hit its highest annual value?
- Moderna cash and short-term investments reached its highest annual value of $10.73B in 2021.
What was Moderna cash and short-term investments in 2024?
- Moderna (MRNA) cash and short-term investments in 2024 was $7.03B.
What was Moderna cash and short-term investments in 2025?
- Moderna (MRNA) cash and short-term investments in 2025 was $5.80B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.